Stuart Weisbrod and Jacob Gottlieb are well-known fund managers that did some important work together at a company called Merlin BioMed Group. This pair of entrepreneurs now finds themselves once again in close proximity to each other as they have recently started to share the same office space. Jacob Gottlieb and Stuart Weisbrod are also planning to do some interesting collaborations with one another now that this situation has materialized.
Merlin was the creation of Stuart Weisbrod and Jacob Gottlieb was one of his critical team members that helped the firm to achieve massive success. The investment management firm had as its primary focus, the emerging field of biotech in the healthcare sector as well as the medical device and the pharmaceutical sector. Stuart Weisbrod brought on Jacob Gottlieb in the capacity of portfolio manager and he proceeded to do some outstanding work. Jacob Gottlieb led Merlin to a return that exceeded one-hundred percent. This occurred during 1999 and 2000 during a very exciting time for the biotech field.
In the wake of his time at Merlin, Jacob Gottlieb went on to found an asset management outfit called Visium. During this time, he experienced massive success and accomplished the impressive feat of turning his initial capital of $300 million into $2.5 billion. The company also weathered 2008’s financial crash and the company’s fortunes continued to shine as the company became a hedge fund worth $8 billion. Jacob Gottlieb is now working hard on his newest hedge fund project called Altium. Following his past successes in the field, Altium is already investing into the healthcare industry and has bought a stake in Oramed Pharmaceuticals Inc. This company has the potential to drastically change the lives of countless people who suffer from the condition of diabetes. The fact that he is running this new venture in the same office space as Stuart Weisbrod certainly suggests that great things could be coming from this pair again soon.